ANTHELMINTIC DRUG DISCOVERY: INTO THE FUTURE

被引：81

作者：

Geary, Timothy G. ^{[1
]}

Sakanari, Judy A. ^{[1
]}

Caffrey, Conor R. ^{[1
]}

机构：

[1] McGill Univ, Inst Parasitol, Quebec City, PQ H9X 3V9, Canada

来源：

JOURNAL OF PARASITOLOGY | 2015年 / 101卷 / 02期

关键词：

SCHISTOSOMA-MANSONI INVITRO; ON-A-CHIP; HIGH-THROUGHPUT; ECHINOCOCCUS-MULTILOCULARIS; ANTIPARASITIC DRUGS; RESISTANCE; BRUGIA; CULTIVATION; WHOLE; 3RD-STAGE;

D O I：

10.1645/14-703.1

中图分类号：

R38 [医学寄生虫学]; Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ; 100103 ;

摘要：

The last half-century has provided all of the (few) drugs currently used to treat human helminthiases. Concern regarding the long-term utility of these drugs, given how readily resistance evolves in the veterinary-agricultural sector, spurs the discovery of new chemical entities. We review the approaches and technologies in use to identify anthelmintics and discuss a number of drug discovery paradigms that may prove pivotal to the next half-century of anthelmintic development.

引用

页码：125 / 133

页数：9

共 50 条

[1] Natural Products Are a Promising Source for Anthelmintic Drug Discovery
Jayawardene, K. L. T. Dilrukshi
Palombo, Enzo A.
Boag, Peter R.
BIOMOLECULES, 2021, 11 (10)
[2] Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics
Sepulveda-Crespo, Daniel
Reguera, Rosa M.
Rojo-Vazquez, Francisco
Balana-Fouce, Rafael
Martinez-Valladares, Maria
MEDICINAL RESEARCH REVIEWS, 2020, 40 (05) : 1715 - 1753
[3] Anthelmintic drug discovery: target identification, screening methods and the role of open science
Partridge, Frederick A.
Forman, Ruth A.
Bataille, Carole J. R.
Wynne, Graham M.
Nick, Marina
Russell, Angela J.
Else, Kathryn J.
Sattelle, David B.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2020, 16 : 1203 - 1224
[4] Antibacterial drug discovery - Then, now and the genomics future
Monaghan, RL
Barrett, JF
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (07) : 901 - 909
[5] Plant Metabolomics: The Future of Anticancer Drug Discovery
Dabbousy, Ranin
Rima, Mohamad
Roufayel, Rabih
Rahal, Mohamad
Legros, Christian
Sabatier, Jean-Marc
Fajloun, Ziad
PHARMACEUTICALS, 2024, 17 (10)
[6] Reimagining the Past: A Future for Antibiotic Drug Discovery in Ophthalmology
Chen, Eric R.
Wozniak, Rachel A. F.
CORNEA, 2024, 43 (01) : 1 - 5
[7] Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery
Herath, H. M. P. Dilrukshi
Taki, Aya C.
Rostami, Ali
Jabbar, Abdul
Keiser, Jennifer
Geary, Timothy G.
Gasser, Robin B.
BIOTECHNOLOGY ADVANCES, 2022, 57
[8] Caenorhabditis elegans is a useful model for anthelmintic discovery
Burns, Andrew R.
Luciani, Genna M.
Musso, Gabriel
Bagg, Rachel
Yeo, May
Zhang, Yuqian
Rajendran, Luckshika
Glavin, John
Hunter, Robert
Redman, Elizabeth
Stasiuk, Susan
Schertzberg, Michael
McQuibban, G. Angus
Caffrey, Conor R.
Cutler, Sean R.
Tyers, Mike
Giaever, Guri
Nislow, Corey
Fraser, Andy G.
MacRae, Calum A.
Gilleard, John
Roy, Peter J.
NATURE COMMUNICATIONS, 2015, 6
[9] AI-Powered Microfluidics: Shaping the Future of Phenotypic Drug Discovery
Liu, Junchi
Du, Hanze
Huang, Lei
Xie, Wangni
Liu, Kexuan
Zhang, Xue
Chen, Shi
Zhang, Yuan
Li, Daowei
Pan, Hui
ACS APPLIED MATERIALS & INTERFACES, 2024, 16 (30) : 38832 - 38851
[10] Expanding the Biological Application of Fluorescent Benzothiadiazole Derivatives: A Phenotypic Screening Strategy for Anthelmintic Drug Discovery Using Caenorhabditis elegans
Cintra, Giovana A. S.
Neto, Brenno A. D.
Carvalho, Pedro H. P. R.
Moraes, Carolina B.
Freitas-Junior, Lucio H.
SLAS DISCOVERY, 2019, 24 (07) : 755 - 765

← 1 2 3 4 5 →